BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18830008)

  • 1. Covered stent for the treatment of recurrent bilateral renal artery in-stent restenosis.
    Yan BP; Kiernan TJ; Rosenfield K
    J Invasive Cardiol; 2008 Oct; 20(10):E288-92. PubMed ID: 18830008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous revascularization of persistent renal artery in-stent restenosis.
    Patel PM; Eisenberg J; Islam MA; Maree AO; Rosenfield KA
    Vasc Med; 2009 Aug; 14(3):259-64. PubMed ID: 19651676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis after stenting of atherosclerotic renal artery stenosis: is there a rationale for the use of drug-eluting stents?
    Zeller T; Rastan A; Rothenpieler U; Müller C
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):125-30. PubMed ID: 16755597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovascular brachytherapy for treatment of bilateral renal artery in-stent restenosis.
    Chrysant GS; Goldstein JA; Casserly IP; Rogers JH; Kurz HI; Thorstad WL; Singh J; Lasala JM
    Catheter Cardiovasc Interv; 2003 Jun; 59(2):251-4. PubMed ID: 12772252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balloon-expandable covered stent therapy of complex endovascular pathology.
    Giles H; Lesar C; Erdoes L; Sprouse R; Myers S
    Ann Vasc Surg; 2008 Nov; 22(6):762-8. PubMed ID: 18922676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of brachytherapy to treat renal artery in-stent restenosis.
    Ellis K; Murtagh B; Loghin C; Muench A; Boccalandro F; Go B; Ahmad M; Burjonroppa S; Rosales O; Smalling RW
    J Interv Cardiol; 2005 Feb; 18(1):49-54. PubMed ID: 15788055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of complex stenoses involving renal artery bifurcations with use of drug-eluting stents.
    Misra S; Sturludottir M; Mathew V; Bjarnason H; McKusick M; Iyer VK
    J Vasc Interv Radiol; 2008 Feb; 19(2 Pt 1):272-8. PubMed ID: 18341961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of intrastent restenosis].
    Eltchaninoff H; Tron C; Sebagh L; Cribier A
    Pathol Biol (Paris); 2004 May; 52(4):218-22. PubMed ID: 15145135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular brachytherapy for patients with drug-eluting stent restenosis.
    Bonello L; Kaneshige K; De Labriolle A; Roy P; Lemesle G; Torguson R; Satler LF; Pichard AD; Lindsay J; Waksman R
    J Interv Cardiol; 2008 Dec; 21(6):528-34. PubMed ID: 18973502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outcomes of drug-eluting stents versus bare-metal stents in nonostial proximal left anterior descending coronary arteries.
    Bonello L; De Labriolle A; Lemesle G; Roy P; Steinberg DH; Slottow TL; Xue Z; Torguson R; Kaneshige K; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):496-500. PubMed ID: 19195509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stent implantation for treatment of recurrent renal artery in-stent restenosis.
    Kakkar AK; Fischi M; Narins CR
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):118-22; discussion 123-4. PubMed ID: 16763993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cutting balloon for in-stent restenosis: a review.
    Bejarano J
    J Interv Cardiol; 2004 Aug; 17(4):203-9. PubMed ID: 15318891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients with in-stent restenosis.
    Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
    EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unintentional extraction of a coronary stent deployed 4 months earlier during cutting-balloon angioplasty for in-stent restenosis.
    Reffelmann T; Hummel A; Felix SB
    J Invasive Cardiol; 2008 Jul; 20(7):E208-9. PubMed ID: 18599904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is drug-eluting stent angioplasty indicated for the treatment of atherosclerotic renal artery stenosis and restenosis?
    Zeller T
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):123-4. PubMed ID: 16763994
    [No Abstract]   [Full Text] [Related]  

  • 20. Three-dimensional balloon catheter sizing identifies significant underdeployed stents using conventional methods in renal artery interventions.
    Aqel RA; Zoghbi GJ; Hage FG; Dell'Italia L
    J Invasive Cardiol; 2008 Jun; 20(6):270-6. PubMed ID: 18523318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.